MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
Accelerate Diagnostics ROE Ratio 2011-2026 | AXDX
Annual ROE Ratio Accelerate Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 65.62 | 65.02 | 124.51 | 1142.5 | -153.95 | -53.94 | -85.3 | -34.2 | -46.87 | -36.81 | -35.8 | -7.87 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1142.5 | -153.95 | 78.58 |
Quarterly ROE Ratio Accelerate Diagnostics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58.22 | 112.69 | 125.44 | 284.59 | 446.34 | 391.57 | 213.07 | 278.08 | 141.54 | 142.72 | 155.23 | 120.32 | 127.57 | 127.11 | 124.51 | 383.53 | 630.59 | 882.06 | 1142.5 | 814.69 | 499.25 | 176.69 | -153.95 | -129.0 | -104.87 | -78.25 | -53.94 | -60.95 | -68.79 | -77.89 | -85.3 | -74.46 | -60.64 | -46.89 | -34.2 | -37.59 | -42.54 | -45.68 | -46.87 | -46.02 | -41.81 | -38.55 | -36.81 | -27.06 | -49.7 | -49.92 | -57.58 | -55.48 | -32.93 | -22.77 | -17.91 | -9.24 | 0.85 | -8.94 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1142.5 | -153.95 | 105.23 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
BioNano Genomics
BNGO
|
-59.42 | $ 1.13 | - | $ 6.15 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 16.07 | -0.28 % | $ 173 M |  China |
 |
Agilent Technologies
A
|
22.45 | $ 115.27 | 0.17 % | $ 35 B | USA |
 |
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 16.35 | 1.87 % | $ 871 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 2.25 | -2.17 % | $ 9.95 M | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 1.38 | 0.91 % | $ 1.84 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 23.14 | 0.04 % | $ 643 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 176.98 | 0.74 % | $ 8.77 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 496.91 | 0.68 % | $ 14.3 B | USA |
 |
Danaher Corporation
DHR
|
6.88 | $ 191.04 | 0.78 % | $ 136 B | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 4.45 | 2.18 % | $ 412 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 122.89 | 1.62 % | $ 19.5 B | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 7.9 | 2.67 % | $ 1.01 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 14.96 | 3.64 % | $ 452 M | USA |
 |
Guardant Health
GH
|
419.18 | $ 79.03 | 0.54 % | $ 9.91 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 2.76 | 2.6 % | $ 89.6 K | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.07 | -3.27 % | $ 4.75 M | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 28.14 | -0.58 % | $ 20 B | Niderland |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 107.18 | 0.35 % | $ 8.84 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 260.85 | -0.03 % | $ 21.7 B | USA |
 |
Natera
NTRA
|
-77.62 | $ 197.77 | 2.46 % | $ 19.5 B | USA |
 |
Celcuity
CELC
|
-176.06 | $ 118.02 | 0.75 % | $ 5.52 B | USA |
 |
Senseonics Holdings
SENS
|
-113.21 | $ 6.61 | -1.05 % | $ 276 M | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 80.46 | -0.17 % | $ 5.43 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 190.61 | -0.48 % | $ 21.2 B | USA |
 |
Soleno Therapeutics
SLNO
|
4.64 | $ 52.6 | -0.06 % | $ 2.67 B | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.09 | -3.56 % | $ 1.97 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-310.93 | $ 5.0 | 1.21 % | $ 3.94 M | USA |
 |
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M | USA |